Download presentation
Presentation is loading. Please wait.
Published byConstance Bédard Modified over 5 years ago
1
Mean change in patient-reported outcomes from baseline to Week 25 with biweekly or monthly pegloticase compared with placebo. Mean change in patient-reported outcomes from baseline to Week 25 with biweekly or monthly pegloticase compared with placebo. SF-6D: preference-based single index health measure; PCS: physical component summary; HAQ-DI: Health Assessment Questionnaire-Disability Index; MCID: minimum clinically important difference. VIBEKE STRAND et al. J Rheumatol 2012;39: ©2012 by The Journal of Rheumatology
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.